[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356495-105":59,"doc-detail-356495-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","green-synthesis-of-zinc-oxide-nanoparticles-and-their-application-in-anticancer-drug-delivery-a-review","Green Synthesis of Zinc Oxide Nanoparticles and Their Application in Anticancer Drug Delivery - A Review","","Metal and metal oxide nanoparticles support important biomedical and pharmaceutical uses, especially as anticancer drug carriers. This review focuses exclusively on biosynthesized zinc oxide nanoparticles (ZnO NPs) for targeted anticancer drug delivery, highlighting their unique properties and biocompatible behavior. Green synthesis using natural products and living organisms offers eco-friendliness, lower cost, and well-defined size and morphology. Bioactive capping agents enhance stability, biocompatibility and targeting, while comparative synthesis analysis and applications for multiple anticancer drugs are surveyed. Remaining barriers include synthesis challenges, toxicity, scalability, and incomplete biochemical mechanism understanding, and translation to clinical trials requires multidisciplinary collaboration.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/green-synthesis-of-zinc-oxide-nanoparticles-and-their-application-in-anticancer-drug-delivery-a-review/356495/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/green-synthesis-of-zinc-oxide-nanoparticles-and-their-application-in-anticancer-drug-delivery-a-review/356495.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the review on zinc oxide nanoparticles?","Question",{"text":112,"@type":113},"The review concentrates on biosynthesized zinc oxide nanoparticles (ZnO NPs) as targeted anticancer drug delivery nanocarriers and summarizes their synthesis and applications.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why are ZnO nanoparticles considered promising for anticancer drug delivery?",{"text":117,"@type":113},"ZnO NPs are highlighted for unique properties, biocompatibility, and the ability to support targeted delivery that may improve stability, biocompatibility, and targeting through bioactive capping agents.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges limit clinical translation of biosynthesized ZnO NPs?",{"text":121,"@type":113},"Key challenges include synthesis-related issues, toxicity, scalability of production, and limited understanding of biochemical mechanisms governing reduction and stabilization of metal ions by biological agents.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356495,1790245263,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","International Journal of Nanomedicine  \n Open Access Full Text Article  \nREVIEW  \nGreen Synthesis of Zinc Oxide Nanoparticles and Their Application in Anticancer Drug Delivery – A Review  \nKatarzyna Łukowiak , Elżbieta U Stolarczyk   \nSpectrometric Methods Department, National Medicines Institute, Warsaw, 00-725, Poland  \nCorrespondence: Katarzyna Łukowiak, Spectrometric Methods Department, National Medicine Institute, 30/34 Chełmska Street, Warsaw, 00-725, Poland, Tel +48 22 8412121, Email [k.lukowiak@nil.gov.pl](k.lukowiak@nil.gov.pl)  \n\n| Abstract: Metal and metal oxide nanoparticles have many promising applications in biomedicine and pharmacy. One of the applications that has been widely studied over the last decade is their use as anticancer drug carriers. This review fills a gap in the literature by concentrating exclusively on biosynthesized zinc oxide nanoparticles (ZnO NPs) for targeted anticancer drug delivery. ZnO NPs have been suggested as a feasible prospect, among other metal-based NPs, because of their unique properties and biocompatible nature. The use of ZnO NPs in drug delivery could reduce the dosage of drugs used for cancer treatment and reduce other side effects, by aiming the specific sites of cancer cells. Green methods of synthesis, with the use of natural products and living organisms, have become very popular in last decades due to their numerous advantages. They are not only eco-friendly and less expensive but they also allow to avoid the waste of energy and receive the NPs with well-defined size and morphology. The biosynthesized ZnO NPs have inherent advantages because they are made with the use of bioactive capping agents. Therefore, they show enhanced performance in drug delivery as they have improved stability, biocompatibility and targeting. This review includes a comparative analysis of synthesis methods and a comprehensive survey of their application as nanocarriers for various anticancer drugs. Their development faces several challenges related to synthesis, toxicity, scalability of the process, and limited understanding of the biochemical mechanisms involved in reduction and stabilization of metal ions through biological agents. Although biosynthesized ZnO NPs show a lot of potential as nanocarriers in laboratory conditions, their use in clinical trials is very challenging and requires collaboration between scientists, process engineers, clinicians and regulatory agencies. However, if these challenges are addressed and treated properly, their full commercial value and widespread applications will be enabled.\u003Cbr>Keywords: biosynthesis, cancer, targeted drug delivery, nanocarriers, ZnO nanoparticles, green chemistry |\n| --- |\n| Introduction\u003Cbr>A diverse application of nanomaterials has opened a new horizon in engineering over the past two decades.1,2 The term nanomaterial refers to materials with sizes in the range of 1–100 nm. Nanoparticles are manufactured to achieve unique physical and chemical properties that result from their small size, shape, surface area, and conductivity.3–8 Nanoparticles have been considered as a potential candidate for targeted drug delivery due to their biocompatibility, ease of synthesis, low costs of metal precursors, and successful cellular internalization via endocytosis. The smaller size and larger surface area, as compared to the bulk material, make it easier for NPs to penetrate cell membranes and enable their absorption into cells, that results in better distribution. Different types of NPs are loaded with drugs that reach their targets in strictly defined quantities and then guide the drug release from the nanoparticles.1,2,9–13 NPs vectors aid in the delivery of hydrophobic drugs, poorly water-soluble drugs, and co-delivery of more than one drug to a specific site due to multiple functionalizations on the NPs surface.9\u003Cbr>Among the metal and metal oxide nanoparticles, ZnO NPs have been extensively used in various biological applications due to their bioc","cbCaiaUbpKSsFADZ","https://ap.wps.com/l/cbCaiaUbpKSsFADZ","pdf",4674332,24,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What is the main focus of the review on zinc oxide nanoparticles?\",\"answer\":\"The review concentrates on biosynthesized zinc oxide nanoparticles (ZnO NPs) as targeted anticancer drug delivery nanocarriers and summarizes their synthesis and applications.\"},{\"question\":\"Why are ZnO nanoparticles considered promising for anticancer drug delivery?\",\"answer\":\"ZnO NPs are highlighted for unique properties, biocompatibility, and the ability to support targeted delivery that may improve stability, biocompatibility, and targeting through bioactive capping agents.\"},{\"question\":\"What challenges limit clinical translation of biosynthesized ZnO NPs?\",\"answer\":\"Key challenges include synthesis-related issues, toxicity, scalability of production, and limited understanding of biochemical mechanisms governing reduction and stabilization of metal ions by biological agents.\"}]","Green Synthesis of Zinc Oxide Nanoparticles and Their Application in Anticancer Drug Delivery - A Review | PDF",1790125577,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce9bc99a70a18a2162696bb73045b21b.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b97ba742f73a928e6e36d2aa16323964.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80ca4bba67eee7a10b4195a8bc6be252.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7c74fc4ec8c4d7c7b1673a3d884fb1c.webp",980,1268]